Search Results - "Fang, Jiequn"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    MiR-204-3p Inhibited the Proliferation of Bladder Cancer Cells via Modulating Lactate Dehydrogenase-Mediated Glycolysis by Guo, Jinan, Zhao, Pan, Liu, Zengqin, Li, Zaishang, Yuan, Yeqing, Zhang, Xueqi, Yu, Zhou, Fang, Jiequn, Xiao, Kefeng

    Published in Frontiers in oncology (29-11-2019)
    “…MicroRNAs (miRNAs) are endogenous non-coding RNAs that negatively regulate the expression of downstream targeted mRNAs. Increasing evidence has suggested that…”
    Get full text
    Journal Article
  2. 2

    Safety and Activity of Programmed Cell Death 1 Versus Programmed Cell Death Ligand 1 Inhibitors for Platinum-Resistant Urothelial Cancer: A Meta-Analysis of Published Clinical Trials by Li, Zaishang, Li, Xueying, Lam, Wayne, Cao, Yabing, Han, Hui, Zhang, Xueqi, Fang, Jiequn, Xiao, Kefeng, Zhou, Fangjian

    Published in Frontiers in oncology (01-04-2021)
    “…Programmed death 1/ligand 1 (PD-1/L1) inhibitors have acceptable antitumor activity in patients with platinum-resistant urothelial cancer (UC). However, the…”
    Get full text
    Journal Article
  3. 3

    Establishing a Urine-Based Biomarker Assay for Prostate Cancer Risk Stratification by Guo, Jinan, Liu, Dale, Zhang, Xuhui, Johnson, Heather, Feng, Xiaoyan, Zhang, Heqiu, Wu, Alan H B, Chen, Lingwu, Fang, Jiequn, Xiao, Zhangang, Xiao, Kefeng, Persson, Jenny L, Zou, Chang

    “…One of the major features of prostate cancer (PCa) is its heterogeneity, which often leads to uncertainty in cancer diagnostics and unnecessary biopsies as…”
    Get full text
    Journal Article
  4. 4

    Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: A meta-analysis of results from multivariate analysis by Guo, Jinan, Fang, Jiequn, Huang, Xiangjiang, Liu, Yanfeng, Yuan, Yeqing, Zhang, Xueqi, Zou, Chang, Xiao, Kefeng, Wang, Jianhong

    “…The prognostic role of neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) in patients with prostate cancer (PCa) remains inconsistent…”
    Get full text
    Journal Article
  5. 5

    Can American Joint Committee on Cancer prognostic groups be individualized in patients undergoing surgery for Stage IV invasive upper tract Urothelial Carcinoma? by Li, Zaishang, Li, Xueying, Liu, Ying, Fang, Jiequn, Zhang, Xueqi, Xiao, Kefeng

    Published in Journal of Cancer (01-01-2021)
    “…We explored whether the modified American Joint Committee on Cancer tumor-node-metastasis prognostic stage group IV can be individualized in a large…”
    Get full text
    Journal Article